24 /100
LOW RISK
Score updated May 28, 2026

CLDI — Calidi Biotherapeutics, Inc. Dilution Risk Tracker

Track CLDI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CLDI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.24 below $1 exchange minimum
🔔 Track CLDI — Get forecast alerts →

💹 Market Data

Market Cap$3.69M
Shares Outstanding19.31M
Float10.72M
Cash$9.60M
Debt$623.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 112.0% shares (2025Q4 vs prior)
27 institutional holders · 448.4K shares
#1 DRW Securities, LLC 147.8K shares
#2 HighTower Advisors, LLC 83.5K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 41.9K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.04M
Days to Cover1.0
% of Float28.4%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2024
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track CLDI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CLDI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADM
🔬 More Research for CLDI
📊 CLDI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CLDI Signal Convergence & Dark Pool Activity — StonkWhisper 📄 CLDI Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.